Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Valeant takes over Probiotica in Brazil
The transaction is expected to be immediately accretive. Probiotica currently markets a full line of OTC sports nutrition products and other food supplements, with a 30% share of
The transaction is expected to be immediately accretive. Probiotica currently markets a full line of OTC sports nutrition products and other food supplements, with a 30% share of
The deployment has been achieved with the use Zenlife a proprietary accelerator tool, and the use of various solution frameworks, regulatory expertise, and consulting capabilities in Life Sciences,
As per the agreement, clinical trial sponsors based regionally and internationally will have access to clinical trial services throughout Asia, with a focus on early phase development. Parexel
AFN-1252, the clinical candidate from the company’s FASII program, is designed to selectively target the staphylococcal FabI enzyme. The Phase 2 trial is designed to confirm efficacy and
The products are indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. The products are packaged in blister
Under the contract, Median will employ its LMS platform at all 65 investigator and independent review sites. The aim of the project is to reduce reading variability and
Under the collaboration agreement, Shire will receive exclusive world-wide rights to ZFP Therapeutics designed to target four genes which will be used to investigate curative therapies for hemophilia
The FDA has also agreed that all accelerated post-approval commitments for the indication have been met, which confirms the clinical benefit of adjuvant treatment with Gleevec. The approval
As per the agreement, Impax will even have non-exclusive rights to develop new products containing zolmitriptan and to exclusively commercialize these products in the US in connection with
PharmaSafe is designed to tackle the lack of control and visibility inherent in the involvement of too many parties. TNT controls the full supply chain, from packaging procurement